Del Carmen Jeffrey, Chief Commercial Officer at Catalyst Pharmaceuticals ($CPRX), sold shares once on the open market in the last 365 days for a total of $256 thousand. His most recent sale occurred on November 26, 2025. These sales rank 7,899th among 11,678 individual insiders, where the average is $8.6 million across 6.37 transactions. Jeffrey made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common Stock, par value $0.001 per share | 8667 | $0.00 | 18,176.0000 | 127,201,954 | 91.15% | 0.01% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common Stock, par value $0.001 per share | 3839 | $0.00 | 14,337.0000 | 127,201,954 | 21.12% | 0.00% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 8667 | $0.00 | 1,036,846.0000 | 127,201,954 | 0.83% | 0.01% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 8039 | $0.00 | 1,045,513.0000 | 127,201,954 | 0.76% | 0.01% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common Stock, par value $0.001 per share | 2492 | $0.00 | 9,509.0000 | 127,201,954 | 20.76% | 0.00% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common Stock, par value $0.001 per share | 8039 | $0.00 | 12,001.0000 | 127,201,954 | 202.90% | 0.01% |
| Nov. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common Stock, par value $0.001 per share | 10983 | $23.33 | 3,962.0000 | 127,201,954 | 73.49% | 0.01% |
| Nov. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common Stock, par value $0.001 per share | 10983 | $4.21 | 14,945.0000 | 127,201,954 | 277.21% | 0.01% |
| Nov. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Options to purchase common stock | 10983 | $0.00 | 1,053,552.0000 | 127,201,954 | 1.05% | 0.01% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Options to purchase common stock | 106873 | $0.00 | 1,037,881.0000 | 127,201,954 | 11.48% | 0.08% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common Stock, par value $0.001 per share | 1641 | $0.00 | 3,962.0000 | 127,201,954 | 29.29% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common Stock, par value $0.001 per share | 5603 | $0.00 | 5,603.0000 | 127,201,954 | 9999.99% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 5603 | $0.00 | 1,064,535.0000 | 127,201,954 | 0.52% | 0.00% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Restricted Stock Units | 32257 | $0.00 | 1,070,138.0000 | 127,201,954 | 3.11% | 0.03% |
| March 3, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 30423 | $22.89 | 0.0000 | 124,943,603 | 100.00% | 0.02% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 10667 | $0.00 | 931,008.0000 | 124,943,603 | 1.13% | 0.01% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 10667 | $0.00 | 33,548.0000 | 124,943,603 | 46.62% | 0.01% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3125 | $0.00 | 30,423.0000 | 124,943,603 | 9.32% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 8667 | $0.00 | 941,675.0000 | 125,407,279 | 0.91% | 0.01% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3839 | $0.00 | 22,881.0000 | 125,407,279 | 14.37% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 8667 | $0.00 | 26,720.0000 | 125,407,279 | 48.01% | 0.01% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 2355 | $0.00 | 18,053.0000 | 125,407,279 | 11.54% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 8039 | $0.00 | 20,408.0000 | 125,407,279 | 64.99% | 0.01% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 8039 | $0.00 | 950,342.0000 | 125,407,279 | 0.84% | 0.01% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Restricted Stock Units | 16809 | $0.00 | 958,381.0000 | 125,407,279 | 1.72% | 0.01% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Options to purchase common stock | 137553 | $0.00 | 941,572.0000 | 125,407,279 | 12.75% | 0.11% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 30000 | $18.42 | 12,369.0000 | 113,753,154 | 70.81% | 0.03% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 6058 | $18.44 | 12,369.0000 | 113,753,154 | 32.88% | 0.01% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 30000 | $2.86 | 42,369.0000 | 113,753,154 | 242.54% | 0.03% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Options to purchase common stock | 30000 | $0.00 | 804,019.0000 | 113,753,154 | 3.60% | 0.03% |
| June 7, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 7541 | $16.07 | 18,427.0000 | 113,753,154 | 29.04% | 0.01% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 10667 | $0.00 | 834,019.0000 | 113,753,154 | 1.26% | 0.01% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 10667 | $0.00 | 29,093.0000 | 113,753,154 | 57.89% | 0.01% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3125 | $0.00 | 25,968.0000 | 113,753,154 | 10.74% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 8666 | $0.00 | 22,265.0000 | 111,375,631 | 63.73% | 0.01% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3839 | $0.00 | 18,426.0000 | 111,375,631 | 17.24% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 8666 | $0.00 | 844,686.0000 | 111,375,631 | 1.02% | 0.01% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Options to purchase common stock | 167918 | $0.00 | 829,235.0000 | 111,375,631 | 25.39% | 0.15% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | A | Restricted Stock Units | 24117 | $0.00 | 853,352.0000 | 111,375,631 | 2.91% | 0.02% |
| June 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3942 | $0.00 | 13,599.0000 | 111,375,631 | 22.47% | 0.00% |
| June 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 10000 | $0.00 | 661,317.0000 | 111,375,631 | 1.49% | 0.01% |
| June 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 10000 | $0.00 | 17,541.0000 | 111,375,631 | 132.61% | 0.01% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Options to purchase common stock | 19017 | $0.00 | 671,317.0000 | 111,375,631 | 2.75% | 0.02% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 19017 | $16.69 | 7,541.0000 | 111,375,631 | 71.61% | 0.02% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 19017 | $4.21 | 26,558.0000 | 111,375,631 | 252.18% | 0.02% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S | Common stock, par value $0.001 per share | 20983 | $16.70 | 7,541.0000 | 111,375,631 | 73.56% | 0.02% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 20983 | $2.24 | 28,524.0000 | 111,375,631 | 278.25% | 0.02% |
| March 29, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Options to purchase common stock | 20983 | $0.00 | 690,334.0000 | 111,375,631 | 2.95% | 0.02% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | F | Common stock, par value $0.001 per share | 3125 | $0.00 | 7,541.0000 | 111,375,631 | 29.30% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Restricted Stock Units | 10666 | $0.00 | 711,317.0000 | 111,375,631 | 1.48% | 0.01% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Del Carmen Jeffrey | Chief Commercial Officer | M | Common stock, par value $0.001 per share | 10666 | $0.00 | 10,666.0000 | 111,375,631 | 9999.99% | 0.01% |